An new Phase 1 clinical trial using chimeric antigen receptor (CAR) T-cell therapy to attack pleural mesothelioma tumors shows promise for cancer patients.
New type of immunogene therapy, also called virotherapy, is the subject of a Phase 3 clinical trial for patients with pleural mesothelioma.
Inez St. John was diagnosed with indirect mesothelioma. Read more about her experience and what you need to know.
The medical community may soon have a new resource to help in the fight against mesothelioma: a national patient registry.